A recent study published in Cell reveals that the repeated DNA sequence that leads to Huntington’s disease (HD) expands ...

The company’s products include INGREZZA for tardive dyskinesia and chorea associated with Huntington ... NBI-1076986 to treat movement disorders; crinecerfront to treat congenital adrenal ...

clinicians should note the patient's distinct movement patterns and how they progress. "Stereotypies, chorea, athetosis, and dystonia are the top four movements associated with tardive dyskinesia ...

The first step to diagnosis depends critically on an accurate description of the abnormal movement. Tremor, dystonia, chorea, and myoclonus are dyskinesias recognised to reflect neurological disease.

Sage Therapeutics' financials indicate a need for additional funding in 2025, risking dilution and further financial ...

SOM3355 (bevantolol hydrochloride) hit its objectives in a phase 2 trial in patients with Huntington's disease, improving the involuntary, jerky movements known as chorea that are a key symptom of ...

Teva Pharmaceuticals USA Inc. is taking the Biden administration to court over its drug price negotiation program, days ...

The hallmark symptom of Huntington's disease is the presence of progressive chorea (abnormal involuntary movements), which is accompanied by psychiatric symptoms and cognitive decline. A ...

After reinvigorating a decades-old schizophrenia drug in an innovative long-acting treatment option, Teva is looking to unlock its next chapter of mental health treatment. TEV’749 is a long ...

The following search terms were used: OCD, obsessive–compulsive symptoms, movement disorder, hyperkinesia, chorea, Huntington's disease, myoclonus dystonia, generalised dystonia, idiopathic focal ...

jerky movements known as chorea, which both affect the dopamine pathway. Crucially, the subgroup analysis was prespecified in the trial protocol, recognising the difficulty of enrolling HD ...